# AET09 variant 1 is produced correctly, AE related to study drug

    Code
      res
    Output
                                                                                          A: Drug X    B: Placebo    C: Combination   All Patients
                                                                                           (N=134)       (N=134)        (N=132)         (N=400)   
      ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event related to study drug     105 (78.4%)   108 (80.6%)    109 (82.6%)     322 (80.5%) 
      Overall total number of events related to study drug                                   282           299            336             917     
      cl D.2                                                                                                                                      
        Total number of patients with at least one adverse event related to study drug   47 (35.1%)    58 (43.3%)      57 (43.2%)     162 (40.5%) 
        Total number of events related to study drug                                         62            72              74             208     
        dcd D.2.1.5.3                                                                    47 (35.1%)    58 (43.3%)      57 (43.2%)     162 (40.5%) 
      cl D.1                                                                                                                                      
        Total number of patients with at least one adverse event related to study drug   50 (37.3%)    42 (31.3%)      51 (38.6%)     143 (35.8%) 
        Total number of events related to study drug                                         61            51              71             183     
        dcd D.1.1.1.1                                                                    50 (37.3%)    42 (31.3%)      51 (38.6%)     143 (35.8%) 
      cl B.1                                                                                                                                      
        Total number of patients with at least one adverse event related to study drug   47 (35.1%)    49 (36.6%)      43 (32.6%)     139 (34.8%) 
        Total number of events related to study drug                                         56            60              62             178     
        dcd B.1.1.1.1                                                                    47 (35.1%)    49 (36.6%)      43 (32.6%)     139 (34.8%) 
      cl C.2                                                                                                                                      
        Total number of patients with at least one adverse event related to study drug   35 (26.1%)    48 (35.8%)      55 (41.7%)     138 (34.5%) 
        Total number of events related to study drug                                         48            53              65             166     
        dcd C.2.1.2.1                                                                    35 (26.1%)    48 (35.8%)      55 (41.7%)     138 (34.5%) 
      cl C.1                                                                                                                                      
        Total number of patients with at least one adverse event related to study drug   43 (32.1%)    46 (34.3%)      43 (32.6%)      132 (33%)  
        Total number of events related to study drug                                         55            63              64             182     
        dcd C.1.1.1.3                                                                    43 (32.1%)    46 (34.3%)      43 (32.6%)     132 (33.0%) 

# AET09 variant 2 is produced correctly, AE related to study drug (including high-level terms)

    Code
      res
    Output
                                                                                            A: Drug X    B: Placebo    C: Combination
                                                                                             (N=134)       (N=134)        (N=132)    
      ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event related to study drug       105 (78.4%)   108 (80.6%)    109 (82.6%)  
      Overall total number of events related to study drug                                     282           299            336      
      cl D.2                                                                                                                         
        Total number of patients with at least one adverse event related to study drug     47 (35.1%)    58 (43.3%)      57 (43.2%)  
        Total number of events related to study drug                                           62            72              74      
        hlt D.2.1.5                                                                                                                  
          Total number of patients with at least one adverse event related to study drug   47 (35.1%)    58 (43.3%)      57 (43.2%)  
          Total number of events related to study drug                                         62            72              74      
          dcd D.2.1.5.3                                                                    47 (35.1%)    58 (43.3%)      57 (43.2%)  
      cl D.1                                                                                                                         
        Total number of patients with at least one adverse event related to study drug     50 (37.3%)    42 (31.3%)      51 (38.6%)  
        Total number of events related to study drug                                           61            51              71      
        hlt D.1.1.1                                                                                                                  
          Total number of patients with at least one adverse event related to study drug   50 (37.3%)    42 (31.3%)      51 (38.6%)  
          Total number of events related to study drug                                         61            51              71      
          dcd D.1.1.1.1                                                                    50 (37.3%)    42 (31.3%)      51 (38.6%)  
      cl B.1                                                                                                                         
        Total number of patients with at least one adverse event related to study drug     47 (35.1%)    49 (36.6%)      43 (32.6%)  
        Total number of events related to study drug                                           56            60              62      
        hlt B.1.1.1                                                                                                                  
          Total number of patients with at least one adverse event related to study drug   47 (35.1%)    49 (36.6%)      43 (32.6%)  
          Total number of events related to study drug                                         56            60              62      
          dcd B.1.1.1.1                                                                    47 (35.1%)    49 (36.6%)      43 (32.6%)  
      cl C.2                                                                                                                         
        Total number of patients with at least one adverse event related to study drug     35 (26.1%)    48 (35.8%)      55 (41.7%)  
        Total number of events related to study drug                                           48            53              65      
        hlt C.2.1.2                                                                                                                  
          Total number of patients with at least one adverse event related to study drug   35 (26.1%)    48 (35.8%)      55 (41.7%)  
          Total number of events related to study drug                                         48            53              65      
          dcd C.2.1.2.1                                                                    35 (26.1%)    48 (35.8%)      55 (41.7%)  
      cl C.1                                                                                                                         
        Total number of patients with at least one adverse event related to study drug     43 (32.1%)    46 (34.3%)      43 (32.6%)  
        Total number of events related to study drug                                           55            63              64      
        hlt C.1.1.1                                                                                                                  
          Total number of patients with at least one adverse event related to study drug   43 (32.1%)    46 (34.3%)      43 (32.6%)  
          Total number of events related to study drug                                         55            63              64      
          dcd C.1.1.1.3                                                                    43 (32.1%)    46 (34.3%)      43 (32.6%)  

